Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This trial is conducted in Asia, Europe, Middle East, and North America. The primary objective of the trial is to evaluate the safety of Recombinant Activated Factor VII in patients with brain contusions. The secondary objective of the trial is to evaluate the preliminary efficacy of Recombinant Activated Factor VII in preventing early haemorrhagic progression in contusive brain injury.
Epistemonikos ID: b2f7d2d29d34a9faecc56c0536659a0349da85ff
First added on: May 04, 2024